Interferon accumulation in cirrhotic rat liver

Journal of Viral Hepatitis

Volumn 3, Issue 1, 1996, Pages 23-27

  Miyajima, I ^a,b   Sata, M ^a   Gondo, K ^a   Suzuki, H ^a   Tanikawa, K ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE   (Japan)

Author keywords

Autoradiography; Interferon; Liver cirrhosis; Rat

Indexed keywords

COLLAGEN; INTERFERON;

ANIMAL; ARTICLE; AUTORADIOGRAPHY; ELECTRON MICROSCOPY; EXPERIMENTAL LIVER CIRRHOSIS; LIVER; MALE; METABOLISM; PATHOLOGY; RAT; WISTAR RAT;

ANIMALS; AUTORADIOGRAPHY; COLLAGEN; INTERFERONS; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; MICROSCOPY, ELECTRON; RATS; RATS, WISTAR;

EID: 0029691425     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2893.1996.tb00077.x     Document Type: Article

References (20)

1. Hoofnagle JH, Mullen KD, Jones DB et al. Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. N Engl J Med 1986; 315: 1575-1578.
2. Davis GL, Balart LA, Schiff ER et al. Treatment of chronic hepatitis C with recombinant interferon alfa. N Engl J Med 1989; 321: 1501-1506.
3. Di Bisceglie AM, Martin P, Kassianides C et al. Recombinant interferon alfa therapy for chronic hepatitis C. N Engl J Med 1989; 321: 1506-1510.
4. 2a therapy in patients with chronic hepatitis C. Dig Dis Sci 1994; 39: 1273-1280.
5. Omata M, Ito Y, Yokosuka O et al. Randomized, double-blind, placebo-controlled trial of eight-week course of recombinant α-interferon for chronic non-A, non-B hepatitis. Dig Dis Sci 1991; 36: 1217-1222.
6. De Alava E, Camps J, Pardo-Mindán J et al. Histological outcome of chronic hepatitis C treated with a 12-month course of lymphoblastoid alfa interferon. Liver 1993; 13: 73-79.
7. Tsubota A, Chayama K, Ikeda K et al. Factors predictive of response to interferon-α therapy in hepatitis C virus infection. Hepatology 1994; 19: 1088-1094.
8. Jouët P, Roudot-Thoraval F, Dhumeaux D et al. Comparative efficacy of interferon alfa in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitis. Gastroenterology 1994; 106: 686-690.
9. Saito T, Shinzawa H, Kuboki M et al. A randomized, controlled trial of human lymphoblastoid interferon in patients with compensated type C cirrhosis. Am J Gastroenterol 1994; 89: 681-686.
10. Zimmermann T, Müller A, Machnik G et al. Biochemical and morphological studies on production and regression of experimental liver cirrhosis induced by thioacetamide in Uje:WIST rats. Z Versuchstierkd 1987; 30: 165-180.
11. Kato N, Yokosuka O, Hosoda K et al. Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: Increase of the virus in advanced liver disease. Hepatology 1993; 18: 16-20.
12. Honda M, Kaneko S, Sakai A et al. Degree of diversity of hepatitis C virus quasispecies and progression of liver disease. Hepatology 1994; 20: 1144-1151.
13. Hagiwara H, Hayashi N, Mita E et al. Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy. Gastroenterology 1993; 104: 877-883.
14. Kobayashi Y, Watanabe S, Konishi M et al. Quantitation and typing of serum hepatitis C virus RNA in patients with chronic hepatitis C treated with interferon-β. Hepatology 1993; 18: 1319-1325.
15. Kanazawa Y, Hayashi N, Mita E et al. Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients. Hepatology 1994; 20: 1121-1130.
16. Groszmann R J, Kravetz D, Parysow O. Intrahepatic arteriovenous shunting in cirrhosis of the liver. Gastroenterology 1977; 73: 201-204.
17. Groszmann R, Kotelanski B, Cohn JN, Khatri IM. Quantitation of portasystemic shunting from the splenic and mesenteric beds in alcoholic liver disease. Am J Med 1972; 53: 715-722.
18. 123I] iodoamphetamine, and clinical use of the results. Am J Gastroenterol 1994; 89: 86-91.
19. Martinez-Hernandez A, Martinez J. The role of capillarization in hepatic failure: Studies in carbon tetrachloride-induced cirrhosis. Hepatology 1991; 14: 864-874.
20. Miyajima I, Sata M, Uchimura Y et al. Decrease of interferon-induced 2′,5′-oligoadenylate synthetase activity in cirrhotic rat liver. Kansenshogaku Zasshi 1995; 69: 1383-1388.